Is there a difference between clinical angina and experimentally inducible angina? A placebo-controlled experiment in stable coronary artery disease

临床心绞痛和实验诱发心绞痛有区别吗？

• 批准号: MR/S021108/1
• 负责人: Christopher Rajkumar
• 金额: $ 32.39万
• 依托单位: Imperial College London
• 依托单位国家: 英国
• 项目类别: Fellowship
• 财政年份: 2019
• 资助国家: 英国
• 起止时间: 2019 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=MR%2FS021108%2F1
• 关键词: there; difference; between; clinical; angina

Context:Patients often experience chest pain when the heart is short of blood flow due to a narrowing in an artery. We call this symptom 'angina'. We can treat angina with tablets; but sometimes this is not enough, and so doctors open up the narrowing with a metal stent (angioplasty). Unfortunately, some patients still have pains even after this. Perhaps the pain was not caused by the narrowing after all? Cardiologists can test whether a narrowing is restricting blood flow and therefore should have angioplasty. However, there is currently no test to say that a patient's pain is actually caused by the narrowing rather than something else. As a result, cardiologists cannot tell whether angioplasty will alleviate the pain or not. This is an important problem because angioplasty cannot genuinely relieve pain that was not caused by the narrowing, yet such angioplasties still carry risks and cost the NHS tens of millions of pounds per year.Objectives:The principal aim is to test whether we can identify which patients have chest pain that is truly caused by a narrowed artery. In 65 patients who have been referred for angioplasty I will:1. Describe the pattern of chest pain before and after angioplasty.Patients will record the site, nature and severity of each episode of chest pain they experience for 1 month before and 1 month after angioplasty. They will record these episodes on a smartphone application. In this way, we will know how effective the procedure was and which pains were relieved with angioplasty.2. Test whether the pain is actually caused by a narrowed artery.During a normal angioplasty, a miniature balloon is inflated to expand the metal stent. This balloon inflation temporarily blocks blood flow and often causes pain. We will conduct several such balloon inflations to intentionally restrict blood flow and ask the patient to describe their pain in real time. Presumably, if the patient's angina was really caused by the narrowed artery, then blocking the artery should recreate the pain. However, if the narrowed artery was not the cause of their pain, any pain they feel during the experiment would be different in nature. A unique feature of my experiment is that it will be blinded, which means sometimes we really will block the artery and other times it will only be pretend (placebo). The pain should come with the real episodes and not the pretend ones.3. Test whether patients with closely matching symptoms have a better response to angioplasty.If this test, of intentionally blocking the artery, shows a pain closely resembling the patient's usual angina, I speculate that these patients will get a great relief of pain from the angioplasty procedure. In contrast, if this test produces a very different type of pain, I speculate that these patients will not get so much relief from the angioplasty. Applications and benefits:More than 500,000 angioplasty procedures are performed each year for the treatment of angina. This is a major cost to our NHS. Angioplasty is technically excellent at opening the artery. But if a patient's symptoms were not in fact caused by the narrowed artery, even brilliant angioplasty cannot relieve their symptoms. We have not studied enough how the nature of symptoms relates to the narrowed artery. This has been a blind spot in cardiology for many years. My research seeks to resolve this by taking a fresh, personalized, symptom-based approach to angina and angioplasty. If successful, this research could pioneer a new diagnostic test. Such a test could tell us which patients have real angina caused by a narrowed artery, and which patients have chest pain from another source. With this diagnostic ability, cardiologists could better tailor their treatments; identifying the patients in whom stents could most help symptoms, whilst preventing the unnecessary cost and risk associated with angioplasty in those whose symptoms were caused by something else.

背景：当心脏因动脉狭窄而血流不足时，患者经常会出现胸痛。我们称这种症状为“心绞痛”。我们可以用药片治疗心绞痛，但有时这还不够，所以医生用金属支架（血管成形术）打开狭窄。不幸的是，即使在此之后，一些患者仍然感到疼痛。也许疼痛并不是由狭窄引起的？心脏病学家可以测试狭窄是否限制了血流，因此应该进行血管成形术。然而，目前还没有测试表明患者的疼痛实际上是由狭窄而不是其他原因引起的。因此，心脏病专家无法判断血管成形术是否会减轻疼痛。这是一个重要的问题，因为血管成形术不能真正缓解疼痛，不是由狭窄引起的，但这样的血管成形术仍然有风险，并花费NHS每年数千万英镑。目的：主要目的是测试我们是否可以识别哪些患者胸痛是真正由狭窄的动脉引起的。在65例已被转介血管成形术的患者中，我将：1。描述血管成形术前后胸痛的模式。患者将记录血管成形术前1个月和血管成形术后1个月每次胸痛发作的部位、性质和严重程度。他们将在智能手机应用程序上记录这些事件。通过这种方式，我们将知道手术的有效性以及血管成形术缓解了哪些疼痛。测试疼痛是否真的是由狭窄的动脉引起的。在正常的血管成形术中，一个微型球囊膨胀以扩张金属支架。这种球囊膨胀暂时阻止血液流动，并经常导致疼痛。我们将进行几次这样的球囊扩张，以有意地限制血流，并要求患者描述他们真实的疼痛。假设，如果病人的心绞痛真的是由动脉狭窄引起的，那么阻塞动脉应该会重现疼痛。然而，如果狭窄的动脉不是他们疼痛的原因，那么他们在实验过程中感受到的任何疼痛都将是不同的性质。我的实验的一个独特之处是它是盲的，这意味着有时我们真的会阻塞动脉，而其他时候它只是假装的（安慰剂）。疼痛应该伴随着真实的发作而不是假装的发作。测试具有相似症状的患者是否对血管成形术有更好的反应。如果这种故意阻塞动脉的测试显示疼痛与患者通常的心绞痛非常相似，我推测这些患者将从血管成形术中获得极大的疼痛缓解。相反，如果这个测试产生了一种非常不同类型的疼痛，我推测这些患者不会从血管成形术中得到如此多的缓解。应用和益处：每年有超过50万例血管成形术用于治疗心绞痛。这对我们的NHS来说是一个巨大的成本。血管成形术在打开动脉方面技术很好。但是，如果病人的症状实际上不是由狭窄的动脉引起的，即使是聪明的血管成形术也不能缓解他们的症状。我们还没有充分研究症状的性质如何与狭窄的动脉相关。多年来，这一直是心脏病学的盲点。我的研究试图通过采取一种新的、个性化的、基于心绞痛和血管成形术的方法来解决这个问题。如果成功的话，这项研究可以开创一种新的诊断测试。这样的测试可以告诉我们哪些病人患有由动脉狭窄引起的真实的心绞痛，哪些病人的胸痛是由其他原因引起的。有了这种诊断能力，心脏病专家可以更好地定制他们的治疗方法;确定支架最能帮助症状的患者，同时防止那些症状由其他原因引起的患者与血管成形术相关的不必要的成本和风险。

项目成果

Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.

• DOI: 10.1161/jaha.120.017381
• 发表时间: 2021-02-02
• 期刊: Journal of the American Heart Association
• 影响因子: 5.4
• 作者: Foley M;Rajkumar CA;Shun-Shin M;Ganesananthan S;Seligman H;Howard J;Nowbar AN;Keeble TR;Davies JR;Tang KH;Gerber R;O'Kane P;Sharp ASP;Petraco R;Malik IS;Nijjer S;Sen S;Francis DP;Al-Lamee R
• 通讯作者: Al-Lamee R

Correlation of Intravascular Ultrasound and Instantaneous Wave-Free Ratio in Patients With Intermediate Left Main Coronary Artery Disease.

• DOI: 10.1161/circinterventions.120.009830
• 发表时间: 2021-06
• 期刊: Circulation. Cardiovascular interventions
• 作者: El Hajj SC;Toya T;Warisawa T;Nan J;Lewis BR;Cook CM;Rajkumar C;Howard JP;Seligman H;Ahmad Y;Doi S;Nakajima A;Nakayama M;Goto S;Vera-Urquiza R;Sato T;Kikuta Y;Kawase Y;Nishina H;Nakamura S;Matsuo H;Escaned J;Akashi YJ;Davies JE;Lerman A
• 通讯作者: Lerman A

Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.

经皮冠状动脉干预的心肺运动测试和功效：Orbita试验的典型。

• DOI: 10.1093/eurheartj/ehac260
• 发表时间: 2022-09-01
• 期刊: EUROPEAN HEART JOURNAL
• 影响因子: 39.3
• 作者: Ganesananthan, Sashiananthan;Rajkumar, Christopher A.;Foley, Michael;Thompson, David;Nowbar, Alexandra N.;Seligman, Henry;Petraco, Ricardo;Sen, Sayan;Nijjer, Sukhjinder;Thom, Simon A.;Wensel, Roland;Davies, John;Francis, Darrel;Shun-Shin, Matthew;Howard, James;Al-Lamee, Rasha
• 通讯作者: Al-Lamee, Rasha

Why Does a Cardiologist Believe in a Therapy? The Role of Intuitiveness and Understanding the Mechanism.

为什么心脏病专家相信治疗方法？

• DOI: 10.1161/circoutcomes.123.010664
• 发表时间: 2024
• 期刊: Circulation. Cardiovascular quality and outcomes
• 作者: Foley MJ

Optimising physiological endpoints of percutaneous coronary intervention.

优化经皮冠状动脉介入治疗的生理终点。

• DOI: 10.4244/eij-d-20-00988
• 发表时间: 2021
• 期刊: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
• 作者: Al-Lamee R